ENGNW
NASDAQ
$0.34
enGene Holdings Inc - Warrants (31/10/2028) (ENGNW)
enGene Holdings Inc., through its subsidiary enGene, Inc., is a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. The company is headquartered in Saint-Laurent, Canada.
This company is also listed under the following ticker: ENGN.
Website: https://www.engene.comBeta (5Y)
1.35
Price Chart
Profitability
EBITDA-$123M
Growth & Risk
Beta (5Y)1.35
Sharpe Ratio1.03